ATIIW vs GILD
Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Archimedes Tech SPAC Partners II Co. Warrant (ATIIW) is a shell companies company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
ATIIW does not have a complete income-statement cache yet.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ATIIW currently screens at market cap $0. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ATIIW and GILD stock pages for the full models.
Not investment advice.